Corpus ID: 7679717

Cyclosporine-induced sebaceous hyperplasia in a hematopoetic stem cell transplant patient: delayed onset of a common adverse event.

@article{Wilken2016CyclosporineinducedSH,
  title={Cyclosporine-induced sebaceous hyperplasia in a hematopoetic stem cell transplant patient: delayed onset of a common adverse event.},
  author={R. Wilken and M. Fung and V. Shi and M. Cheng and F. Patel and H. Sultani and E. Maverakis},
  journal={Dermatology online journal},
  year={2016},
  volume={22 1}
}
  • R. Wilken, M. Fung, +4 authors E. Maverakis
  • Published 2016
  • Medicine
  • Dermatology online journal
  • Cyclosporine-induced sebaceous hyperplasia (SH) is a well-documented entity, occurring in up to 30% of renal transplant patients treated with cyclosporine and has also been reported to occur following heart or hematopoetic stem cell transplantation (HCST). Cyclosporine has a stimulatory effect on undifferentiated sebocytes, resulting in the clinical and histologic findings in these patients. Sebaceous hyperplasia most commonly presents as asymptomatic papules over the face, chest, or groin… CONTINUE READING
    4 Citations
    Eruptive sebaceous hyperplasia as a side effect of oral tacrolimus in a renal transplant recipient.
    • 2
    • Highly Influenced
    Treatment of sebaceous gland hyperplasia: a review of the literature.

    References

    SHOWING 1-10 OF 29 REFERENCES
    Cyclosporin-induced sebaceous hyperplasia in renal transplant patients.
    • 9
    • PDF
    Cyclosporin-induced sebaceous hyperplasia in renal transplant patients.
    • 14
    Successful treatment of cyclosporine‐induced sebaceous hyperplasia with oral isotretinoin in two renal transplant recipients
    • 25
    Cutaneous lesions in 67 cyclosporin-treated renal transplant recipients.
    • 132
    Ciclosporin A‐induced sebaceous gland hyperplasia
    • 34
    Sebaceous hyperplasia in organ transplant recipients: shared aspects of hyperplastic and dysplastic processes?
    • 55
    • Highly Influential
    [Sebaceous gland hyperplasia as a side effect of cyclosporin A. Treatment with the CO2 laser].
    • 7
    Sebaceous hyperplasia and skin cancer in patients undergoing renal transplant.
    • 32
    • Highly Influential
    [Cutaneous complications following liver transplantation: epidemiologic and clinical study in 86 patients].
    • 19
    Prevalence and clinical spectrum of skin diseases in kidney transplant recipients.
    • 73